# TMates Review: Care Catalogue, Plan Totals and Clinical Limits | HealthspanNerds Canonical: https://healthspannerds.com/reviews/tmates/ Published: 2026-11-03 Updated: 2026-11-03 Evaluate TMates weight care, NAD+ and sermorelin catalogue, longer-plan price equivalents, clinical and pharmacy responsibilities, refund stages and benefit limits. [Reviews](https://healthspannerds.com/providers/)/TMates Prescription care platform # TMates review TMates is worth comparing for a defined care need when the selected product, follow-up and financial agreement are clear. Its catalogue and term totals make several services identifiable, but breadth is not evidence that a reader needs a combination. I would choose the clinical purpose before a longer purchase or an anti-aging claim. EG[Ellis Grant](https://healthspannerds.com/authors/ellis-grant/)Consumer Editor · Updated November 2026 ## A useful next step? Consider the purpose, the care relationship and the full commitment. Visit TMates↗Official provider website. No affiliate relationship is currently listed. ## A reason to consider it Someone who can identify the specific service missing from existing care. - Weight-care, NAD+ and sermorelin products are named separately. - One-month and longer-term totals are visible. - The platform assigns clinical responsibility to independent providers. ## What deserves scrutiny A reader combining products because they share an anti-aging category. - Longer-plan equivalents do not describe one-month purchases. - Payment, renewal and monitoring details need a selected agreement. - Refund provisions include weight-loss-specific language. - A broad catalogue does not demonstrate a combined clinical benefit. ## Choose the missing service rather than the largest catalogue TMates lists compounded weight-care products alongside NAD+ and sermorelin. That breadth can be convenient for someone comparing a particular service, but it is not evidence that several treatments belong in one plan or that the catalogue constitutes a healthy-aging programme. [\[1\]](https://healthspannerds.com/reviews/tmates/#reference-1) [\[2\]](https://healthspannerds.com/reviews/tmates/#reference-2) [\[6\]](https://healthspannerds.com/reviews/tmates/#reference-6) [\[7\]](https://healthspannerds.com/reviews/tmates/#reference-7) I would identify the actual gap in existing care first. A reader already satisfied with clinical follow-up may need a narrower medicine or cost comparison. Someone considering a new prescription needs an individual rationale, not a recommendation inferred from adjacent product cards. Keep the measured outcome in context with [the weight, lean-mass and function review](https://healthspannerds.com/research/weight-loss-lean-mass-function/). ## Attach the total to every lower monthly equivalent The default injectable one-month cards show semaglutide at $249 and tirzepatide at $297. Their twelve-month totals are $1,900 and $1,999, displayed as $158 and $167 per month. Medication, shipping and ongoing support are described as included, but the actual selected supply and care terms need a complete quote. [\[1\]](https://healthspannerds.com/reviews/tmates/#reference-1) [\[2\]](https://healthspannerds.com/reviews/tmates/#reference-2) A monthly equivalent does not settle the debit schedule. The terms contemplate payment arrangements without explaining every public card’s renewal or installment structure. I would compare cash due now, later obligations and reassessment needs together before treating a larger paid term as better value. [\[3\]](https://healthspannerds.com/reviews/tmates/#reference-3) Compare the actual selected payment terms in [the annual care-cost planner](https://healthspannerds.com/tools/cost-planner/). ## The NAD and sermorelin offers need separate judgments Injectable NAD+ lists a $149 one-month plan and a $1,050 twelve-month plan, displayed as $88 per month. Sermorelin lists $179 for one month or $1,550 for twelve, displayed as $129. NAD+ also has a nasal option; its actual preparation and price need their own confirmation. [\[6\]](https://healthspannerds.com/reviews/tmates/#reference-6) [\[7\]](https://healthspannerds.com/reviews/tmates/#reference-7) The category’s cellular-repair and anti-aging language does not establish better function or longer life from buying either service. A clinical reason and appropriate monitoring should stand on their own. The weight-care programme’s inclusions and refund exception should not automatically be transferred to a different prescription. For a separate NAD service and commitment, read [our Embody NAD+ review](https://healthspannerds.com/reviews/embody-nad/). ## A platform is not the prescriber or compounder The August 2025 terms describe independent treating professionals and say TMates does not practice medicine. The footer says it is not a 503A or 503B compounding facility, and that product images are illustrative. Identify the actual preparation, clinician and dispensing pharmacy for the selected order. [\[1\]](https://healthspannerds.com/reviews/tmates/#reference-1) [\[3\]](https://healthspannerds.com/reviews/tmates/#reference-3) FDA explains that compounded drugs do not receive premarket approval. An ingredient or delivery route alone does not establish clinical equivalence to a different finished medicine. Promotional testimonials also cannot supply a controlled comparison of this platform’s effects on weight, recovery, energy or aging. [\[5\]](https://healthspannerds.com/reviews/tmates/#reference-5) Compare a different clinical-and-pharmacy arrangement in [our MyStart Health review](https://healthspannerds.com/reviews/mystart-health/). ## The financial exit depends on the prescription stage The terms promise a full refund before medical-history review, then describe an ineligibility refund specifically for medication-assisted weight-loss plans. They deny refunds once an eligible patient’s prescription is written and transmitted to a pharmacy. Payment plans remain if a refund is not approved. [\[3\]](https://healthspannerds.com/reviews/tmates/#reference-3) That framework should be clarified for the selected product before a long-term agreement. The product’s cancel-anytime line does not establish a universal refund of unused months. Exact renewal dates, required notice and any remaining obligation belong in the written purchase rather than in assumptions drawn from a short headline. Keep the complete purchase visible in [our service comparisons](https://healthspannerds.com/compare/). ## Compare the continuing care, not a promise of transformation The general FAQ describes clinical visits, coaching and medication. It also makes a broad insurance statement, while the terms do not guarantee reimbursement. Neither statement establishes the actual monitoring, contact frequency or coverage of a particular prescription. [\[3\]](https://healthspannerds.com/reviews/tmates/#reference-3) [\[4\]](https://healthspannerds.com/reviews/tmates/#reference-4) LifeMD is a separate clinical-access option for a defined weight-care need; Sprout offers a different bundled comparison. Compare the service that would improve continuity and make the next decision clearer. A broader catalogue or a lower annual equivalent should not decide the clinical plan. For the separate clinical-access comparison, see [our LifeMD review](https://healthspannerds.com/reviews/lifemd/). Compare a different bundled-care service in [our Sprout Health review](https://healthspannerds.com/reviews/sprout-health/). For a separate clinical-access fee and pharmacy payment arrangement, read [our GoodRx weight-care review](https://healthspannerds.com/reviews/goodrx-weight-loss/). ## Understanding the cost Default injectable semaglutide: one month $249; three months $650; six months $1,050; twelve months $1,900 ($158/month displayed equivalent). Injectable tirzepatide: one month $297; three months $800; six months $1,299; twelve months $1,999 ($167/month equivalent). Confirm actual debit schedule, supply, renewal and any separate clinical costs. Oral option pricing is not established by the injectable default. [\[1\]](https://healthspannerds.com/reviews/tmates/#reference-1) [\[2\]](https://healthspannerds.com/reviews/tmates/#reference-2) [\[3\]](https://healthspannerds.com/reviews/tmates/#reference-3) [Build your cost estimate](https://healthspannerds.com/tools/cost-planner/) ## Read alongside this review [the weight, lean-mass and function review](https://healthspannerds.com/research/weight-loss-lean-mass-function/)Keep the studied outcome separate from a service promise. ## Sources - TMates: injectable semaglutide plans and product scope - TMates: injectable tirzepatide plans and product scope - TMates: August 12, 2025 care, payment and refund terms - TMates: care process, programme scope and insurance FAQ - FDA: compounding, approval and patient medical needs - TMates: NAD+ formats and plan totals - TMates: sermorelin programme and plan totals This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.